Kidney disease

Not to be confused with neuropathy.
Nephropathy
Classification and external resources
Specialty urology
ICD-10 N00- N29
MeSH D007674

Kidney disease, also known as nephropathy or renal disease, is damage to or disease of a kidney. Nephritis is inflammatory kidney disease. Nephrosis is noninflammatory nephropathy. Kidney disease usually causes kidney failure (renal failure) to more or less degree, with the amount depending on the type of disease. In precise usage, disease denotes the structural and etiologic disease entity whereas failure denotes the dysfunction (lack of working well, that is, impaired renal function); but in common usage these meanings overlap; for example, the terms chronic kidney disease and chronic renal failure are usually considered synonymous. Acute kidney disease has often been called acute renal failure, although nephrologists now often tend to call it acute kidney injury.

Causes

Causes of kidney disease include deposition of the IgA antibodies in the glomerulus, administration of analgesics, xanthine oxidase deficiency, toxicity of chemotherapy agents, and long-term exposure to lead or its salts. Chronic conditions that can produce nephropathy include systemic lupus erythematosus, diabetes mellitus and high blood pressure (hypertension), which lead to diabetic nephropathy and hypertensive nephropathy, respectively.

Analgesics

Main article: Analgesic nephropathy

One cause of nephropathy is the long term usage of pain medications known as analgesics. The pain medicines which can cause kidney problems include aspirin, acetaminophen, and nonsteroidal anti-inflammatory drugs (NSAIDs). This form of nephropathy is "chronic analgesic nephritis," a chronic inflammatory change characterized by loss and atrophy of tubules and interstitial fibrosis and inflammation (BRS Pathology, 2nd edition).

Specifically, long term use of the analgesic phenacetin has been linked to renal papillary necrosis (necrotizing papillitis).

Diabetes

Main article: Diabetic nephropathy

Diabetic nephropathy is a progressive kidney disease caused by angiopathy of the capillaries in the glomeruli. It is characterized by nephrotic syndrome and diffuse scarring of the glomeruli. It is particularly associated with poorly managed diabetes mellitus and is a primary reason for dialysis in many developed countries. It is classified as a small blood vessel complication of diabetes.[1]

IgA nephropathy

Main article: IgA nephropathy

IgA nephropathy is the most common glomerulonephritis throughout the world [2] Primary IgA nephropathy is characterized by deposition of the IgA antibody in the glomerulus. The classic presentation (in 40-50% of the cases) is episodic frank hematuria which usually starts within a day or two of a non-specific upper respiratory tract infection (hence synpharyngitic) as opposed to post-streptococcal glomerulonephritis which occurs some time (weeks) after initial infection. Less commonly gastrointestinal or urinary infection can be the inciting agent. All of these infections have in common the activation of mucosal defenses and hence IgA antibody production.

Iodinated contrast media

Kidney disease induced by iodinated contrast media (ICM) is called CIN (= contrast induced nephropathy) or contrast-induced AKI (= Acute kidney injury). Currently, the underlying mechanisms are unclear. But there is a body of evidence that several factors including apoptosis-induction seem to play a role.[3]

Lithium

The long term use of lithium, a medication commonly used to treat bipolar disorder and schizoaffective disorders, is known to cause nephropathy.

Xanthine oxidase deficiency

Another possible cause of Kidney disease is due to decreased function of xanthine oxidase in the purine degradation pathway. Xanthine oxidase will degrade hypoxanthine to xanthine and then to uric acid. Xanthine is not very soluble in water; therefore, an increase in xanthine forms crystals (which can lead to kidney stones) and result in damage of the kidney. Xanthine oxidase inhibitors, like allopurinol, can cause nephropathy.

Polycystic disease of the kidneys

Additional possible cause of nephropathy is due to the formation of cysts or pockets containing fluid within the kidneys. These cysts become enlarged with the progression of aging causing renal failure. Cysts may also form in other organs including the liver, brain and ovaries. Polycystic Kidney Disease is a genetic disease caused by mutations in the PKD1, PKD2, and PKHD1 genes. This disease affects about half a million people in the US. Polycystic kidneys are susceptible to infections and cancer.

Toxicity of chemotherapy agents

Main article: Onconephrology

Nephropathy can be associated with some therapies used to treat cancer. The most common form of kidney disease in cancer patients is Acute Kidney Injury (AKI) which can usually be due to volume depletion from vomiting and diarrhea that occur following chemotherapy or occasionally due to kidney toxicities of chemotherapeutic agents. Kidney failure from break down of cancer cells, usually after chemotherapy, is unique to onconephrology. Several chemotherapeutic agents, for example Cisplatin, are associated with acute and chronic kidney injuries.[4] Newer agents such as anti Vascular Endothelial Growth Factor (anti VEGF) are also associated with similar injuries, as well as proteinuria, hypertension and thrombotic microangiopathy.[5]

Development

Kidney disease is a chronic non-communicable disease, having serious consequences if it cannot be controlled effectively. Generally, the process of kidney disease development is from light to serious. The process of most kidney diseases is renal insufficiency, renal failure, and then uremia.

Transplants

Millions of people across the world suffer from kidney disease. Of those millions, several thousand will eventually or do need kidney transplants.[6] Out of those millions in the world, 16,500 in the United States needed a kidney transplant in 2008.[7] Of those 16,500 people, 5,000 died while waiting for a transplant.[8] Currently, there is a shortage of donors, and in 2007 there were only 64,606 kidney transplants in the world. [9] This shortage of donors is causing countries to place monetary value on kidneys. Countries such as Iran and Singapore are eliminating their lists by paying their citizens to donate. Also, the black market accounts for 5-10 percent of transplants that occur worldwide.[10] The act of buying an organ through the black market is illegal in the United States.[11] To be put on the waiting list for a kidney transplant, patients must first be referred by a physician, then they must choose and contact a donor hospital. Once they choose a donor hospital, patients must then receive an evaluation to make sure they are sustainable to receive a transplant. In order to be a match for a kidney transplant, patients must match blood type and human leukocyte antigen factors with their donors. They must also have no reactions to the antibodies from the donor’s kidneys. [12]

References

  1. ↑ Longo et al., Harrison's Principles of Internal Medicine, 18th ed., p.2982
  2. ↑ D'Amico, G (1987). "The commonest glomerulonephritis in the world: IgA nephropathy.". Q J Med 64 (245): 709–727. PMID 3329736.
  3. ↑ Idee, J.-; Boehm, J.; Prigent, P.; Ballet, S.; Corot, C. (2006). "Role of Apoptosis in the Pathogenesis of Contrast Media-induced Nephropathy and Hints for its Possible Prevention by Drug Treatment". Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry 5 (2): 139. doi:10.2174/187152306776872442.
  4. ↑ Portilla D, Safar AM, Shannon ML, Penson RT. Cisplatin nephrotoxicity. In: UpToDate, Palevsky PM (Ed), UpToDate, Waltham, MA, 2013. http://www.uptodate.com/contents/cisplatin-nephrotoxicity
  5. ↑ Robinson, Emily S.; Khankin, Eliyahu V.; Karumanchi, S. Ananth; Humphreys, Benjamin D. (1 November 2010). "Hypertension Induced by Vascular Endothelial Growth Factor Signaling Pathway Inhibition: Mechanisms and Potential Use as a Biomarker". Seminars in Nephrology 30 (6): 591–601. doi:10.1016/j.semnephrol.2010.09.007. PMC 3058726. PMID 21146124.
  6. ↑ Tabarrok, Alex (January 8, 2010). The Meat Market. Wall Street Journal.
  7. ↑ Tabarrok, Alex (January 8, 2010). The Meat Market. Wall Street Journal.
  8. ↑ Tabarrok, Alex (January 8, 2010). The Meat Market. Wall Street Journal.
  9. ↑ Tabarrok, Alex (January 8, 2010). The Meat Market. Wall Street Journal.
  10. ↑ Tabarrok, Alex (January 8, 2010). The Meat Market. Wall Street Journal.
  11. ↑ Scheve, Tom. "How Organ Donations Work". HowStuffWorks. Retrieved 9 March 2015.
  12. ↑ Tabarrok, Alex (January 8, 2010). The Meat Market. Wall Street Journal.

See also

This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.